Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...

Cancer research has rapidly entered a data-rich era. Today, researchers can draw on whole-genome sequencing, single-cell atlases, longitudinal liquid biopsy ...

Artificial intelligence (AI) is increasingly reshaping diagnostic pathology, with breast pathology representing one of the most advanced and clinically impactful areas of adoption.

AI‑guided analysis surfaces a new CAR T target with multi‑cancer activity, as Penn researchers validate GPNMB‑directed CAR T cells in preclinical models.

Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers ...

Researchers at the University of California, Los Angeles have developed a compact, cost-effective diagnostic platform ...